Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 23.20 INR
Change Today 0.00 / 0.00%
Volume 0.0
CPL On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

chemo-pharma laboratories (CPL) Snapshot

Open
23.20
Previous Close
23.20
Day High
23.20
Day Low
23.20
52 Week High
10/10/14 - 37.85
52 Week Low
02/9/15 - 13.20
Market Cap
34.8M
Average Volume 10 Days
20.5
EPS TTM
1.87
Shares Outstanding
1.5M
EX-Date
--
P/E TM
12.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for CHEMO-PHARMA LABORATORIES (CPL)

Related News

No related news articles were found.

chemo-pharma laboratories (CPL) Related Businessweek News

No Related Businessweek News Found

chemo-pharma laboratories (CPL) Details

Chemo Pharma Laboratories Limited does not have significant operations. Previously, the company was engaged in finance and investment activities in India. Chemo Pharma Laboratories Limited was founded in 1942 and is based in Mumbai, India.

chemo-pharma laboratories (CPL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

chemo-pharma laboratories (CPL) Key Developments

Chemo Pharma Laboratories Ltd., Annual General Meeting, Aug 28, 2015

Chemo Pharma Laboratories Ltd., Annual General Meeting, Aug 28, 2015.

Chemo Pharma Laboratories Ltd. Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015

Chemo Pharma Laboratories Ltd. reported unaudited standalone earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported net sales/income from operations of INR 785,000 compared to INR 1,102,000 a year ago. Profit from operations before other income, finance costs and exceptional items was INR 407,000 compared to INR 986,000 a year ago. Net profit from ordinary activities before tax was INR 407,000 compared to INR 986,000 a year ago. Net profit was INR 407,000 or INR 0.27 per basic share before and after extraordinary items compared to INR 986,000 or INR 0.66 per basic share before and after extraordinary items a year ago.

Chemo Pharma Laboratories Ltd. Appoints P. C. Jain as Additional Director of the Company

Chemo Pharma Laboratories Ltd. announced that the Board of Directors of the company at its meeting held on July 23, 2015 has considered and approved Consent Letter of Mr. P. C. Jain and appointed as Additional Director of the Company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CPL:IN 23.20 INR 0.00

CPL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CPL.
View Industry Companies
 

Industry Analysis

CPL

Industry Average

Valuation CPL Industry Range
Price/Earnings 15.1x
Price/Sales 6.7x
Price/Book 0.7x
Price/Cash Flow 15.1x
TEV/Sales 5.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMO-PHARMA LABORATORIES, please visit www.thechemopharmalaboratoriesltd.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.